N/A
N=83
A Clinical Trial of Splinting for DeQuervain's Tenosynovitis
DeQuervain's Tenosynovitis
Bottom Line
View on ClinicalTrials.gov: NCT00438191 ↗Enrolled (actual)
83
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire — 28; 29 units on a scale
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Massachusetts General Hospital
- Primary completion
- Dec 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire |
28; 29 | — |
| SECONDARY Grip Strength |
86; 87 | — |
| SECONDARY Treatment Satisfaction |
6.3; 6.4 | — |
| SECONDARY Pain Intensity |
3.8; 4.4 | — |
Summary
DeQuervain's tenosynovitis is characterized by pain on the pain on the radial (thumb) side of the wrist problems with thumb function. At this point, the standard care is to change daily activities, use a thumb brace, and the possible use of painkillers. There is a difference in opinion among physical therapists about how to use the splint in the treatment of DeQuervain tenosynovitis. Some physicians tell patients to wear the brace at all times while other therapists encourage patients to exercise and use the brace as needed. Both approaches to using the splint are accepted as standard. The purpose of this study is to test and evaluate these two ways of splinting and assess which one is better for patients with DeQuervain tenosynovitis.
Eligibility Criteria
Inclusion Criteria
- Adult patient (age 18 years or greater)
- Physician very confident about the diagnosis of DeQuervain's tenosynovitis.
Exclusion Criteria
- Patients with previous history of surgical treatment for De Quervain's.
- Skin conditions making splint wear problematic.
Data sourced from ClinicalTrials.gov (NCT00438191). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.